Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients

• Published in: PloS one Vol. 8; no. 2; p. e56120
• Main Authors: Ishii, Atsushi, Saito, Yoshiaki, Mitsui, Jun, Ishiura, Hiroyuki, Yoshimura, Jun, Arai, Hidee, Yamashita, Sumimasa, Kimura, Sadami, Oguni, Hirokazu, Morishita, Shinichi, Tsuji, Shoji, Sasaki, Masayuki, Hirose, Shinichi
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 08.02.2013; Public Library of Science (PLoS)
• Subjects: Adenosine triphosphatase; Adenosine triphosphate; Amino Acid Sequence; Amino acids; Analysis; Animals; Asian Continental Ancestry Group - genetics; Base Sequence; Bioinformatics; Biology; Children; Children & youth; Cognitive ability; DNA Mutational Analysis; DNA sequencing; Exome - genetics; Female; Genes; Genetic aspects; Genetic diversity; Hemiplegia; Hemiplegia - genetics; Humans; Infant; Infant, Newborn; Male; Maternal & child health; Medical research; Medicine; Migraine; Missense mutation; Molecular Sequence Data; Mutation; Nervous system; Neurology; Paralysis; Paresis; Patients; Pediatrics; Sequences; Sodium-Potassium-Exchanging ATPase - chemistry; Sodium-Potassium-Exchanging ATPase - genetics; Japan
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0056120

Alternating hemiplegia of childhood (AHC) is a rare disorder characterized by transient repeated attacks of paresis and cognitive impairment. Recent studies from the U.S. and Europe have described ATP1A3 mutations in AHC. However, the genotype-phenotype relationship remains unclear. The purpose of this study was to identify the genetic abnormality in a Japanese cohort of AHC using exome analysis. A total of 712,558 genetic single nucleotide variations in 8 patients with sporadic AHC were found. After a series of exclusions, mutations of three genes were regarded as candidate causes of AHC. Each patient harbored a heterozygous missense mutation of ATP1A3, which included G755C, E815K, C927Y and D801N. All mutations were at highly conserved amino acid residues and deduced to affect ATPase activity of the corresponding ATP pump, the product of ATP1A3. They were de novo mutations and not identified in 96 healthy volunteers. Using Sanger sequencing, E815K was found in two other sporadic cases of AHC. In this study, E815K was found in 5 of 10 patients (50%), a prevalence higher than that reported in two recent studies [19 of 82 (23%) and 7 of 24 (29%)]. Furthermore, the clinical data of the affected individuals indicated that E815K resulted in a severer phenotype compared with other ATP1A3 mutations. Heterozygous de novo mutations of ATP1A3 were identified in all Japanese patients with AHC examined in this study, confirming that ATP1A3 mutation is the cause of AHC.